1
/
of
1
Rescuerel (Human Albumin)
Rescuerel (Human Albumin)
Regular price
₱5,000.00 PHP
Regular price
Sale price
₱5,000.00 PHP
Taxes included.
Quantity
Couldn't load pickup availability
Rescuerel Human Albumin is a sterile, pharmaceutical-grade intravenous solution formulated to restore and maintain blood volume in critical medical situations. Each 50mL vial delivers highly purified human serum albumin, a naturally occurring plasma protein essential for maintaining oncotic pressure and cardiovascular stability.
This therapeutic agent is indicated for emergency treatment of hypovolemic shock resulting from hemorrhage, trauma, or plasma loss, as well as acute hemorrhagic pancreatitis. Rescuerel is a cornerstone intervention in burn management during initial assessment and ongoing burn therapy, helping prevent complications and support tissue perfusion during critical healing phases.
The medication addresses hypoproteinemia with or without edema across multiple etiologies, including liver cirrhosis, hepatitis B infection, and nephrotic syndromes where protein loss or synthesis dysfunction compromises plasma oncotic pressure. Rescuerel is also utilized in managing cerebral edema and neonatal hyperbilirubinemia, where albumin's binding capacity and volume expansion properties provide therapeutic benefit.
By rapidly restoring intravascular volume and preventing cardiovascular collapse, Rescuerel Human Albumin supports vital organ perfusion, stabilizes hemodynamic parameters, and buys critical time in emergency resuscitation protocols. The solution is administered exclusively via intravenous infusion under medical supervision, ensuring precise dosing and clinical monitoring for optimal therapeutic outcomes in life-threatening conditions.
This therapeutic agent is indicated for emergency treatment of hypovolemic shock resulting from hemorrhage, trauma, or plasma loss, as well as acute hemorrhagic pancreatitis. Rescuerel is a cornerstone intervention in burn management during initial assessment and ongoing burn therapy, helping prevent complications and support tissue perfusion during critical healing phases.
The medication addresses hypoproteinemia with or without edema across multiple etiologies, including liver cirrhosis, hepatitis B infection, and nephrotic syndromes where protein loss or synthesis dysfunction compromises plasma oncotic pressure. Rescuerel is also utilized in managing cerebral edema and neonatal hyperbilirubinemia, where albumin's binding capacity and volume expansion properties provide therapeutic benefit.
By rapidly restoring intravascular volume and preventing cardiovascular collapse, Rescuerel Human Albumin supports vital organ perfusion, stabilizes hemodynamic parameters, and buys critical time in emergency resuscitation protocols. The solution is administered exclusively via intravenous infusion under medical supervision, ensuring precise dosing and clinical monitoring for optimal therapeutic outcomes in life-threatening conditions.
Share
